The efficiency of Langerhans‘ cell hystioctosis treatment (3 years follow-up)

O. Baranova, A. Speranskaja, I. Dvorakovskaya, E. Dembo-Smeathon, D. Dzadzua (Saint-Petersburg, Russian Federation)

Source: Annual Congress 2011 - Rare diffuse lung diseases
Session: Rare diffuse lung diseases
Session type: Thematic Poster Session
Number: 636
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Baranova, A. Speranskaja, I. Dvorakovskaya, E. Dembo-Smeathon, D. Dzadzua (Saint-Petersburg, Russian Federation). The efficiency of Langerhans‘ cell hystioctosis treatment (3 years follow-up). Eur Respir J 2011; 38: Suppl. 55, 636

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Silicomicobacteriosis (SM), diagnosis and prognosis, follow up 2,5 years
Source: International Congress 2017 – Silicosis has not gone away
Year: 2017




The evolution of tuberculosis incidence in romanian children (0-14 years) in the last ten years
Source: Eur Respir J 2002; 20: Suppl. 38, 534s
Year: 2002

When do we extend the treatment of tuberculosis (TB) more than 6 months?
Source: Annual Congress 2007 - Clinical tuberculosis
Year: 2007


Influence of an incentive spacer on adherence to prescribed treatment in 2-6 year old children over a 3 month period
Source: Annual Congress 2007 - Childhood asthma: treatment and follow-up
Year: 2007


Lung function abnormalities in asthmatic children (a 3-5 year follow-up study)
Source: Eur Respir J 2001; 18: Suppl. 33, 120s
Year: 2001

Asthma control (AC) and quality of life (QoL) 3 months after pulmonary rehabilitation (PR)
Source: Annual Congress 2010 - Pulmonary rehabilitation: understanding and developing the intervention
Year: 2010

Evaluation of two different therapeutic approaches in the management of patients with sarcoidosis: chest x-ray presentation after 12 months prednisone therapy or observation, in 20 years interval (1976-1980 versus 1996-2000)
Source: Eur Respir J 2004; 24: Suppl. 48, 713s
Year: 2004

Validation of the asthma control questionnaire in children (6-16 years)
Source: Annual Congress 2009 - Clinical advances in childhood asthma
Year: 2009


Which method is effective in patient with asthma to guide the treatment? (2 year follow-up study)
Source: Annual Congress 2009 - Quality of treatment in primary respiratory care
Year: 2009

Lung clearance index (LCI) at age 1-4 years vs lung function and chest X-ray (CXR) scores at age 7 years in children with CF
Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge
Year: 2011

Outcomes of 6-9-12 months’ bedaquiline-containing regimens in MDR/XDR TB after 24 months follow up
Source: International Congress 2018 – Drug-resistant tuberculosis
Year: 2018




Pulmonary thromboembolism in HIV (+) patients under 50 years old: a six year study
Source: Annual Congress 2007 - Venous thromboembolic disease
Year: 2007


Four years follow-up of exacerbations in a cohort of COPD patients: 1 year interim results (EXACO study)
Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects
Year: 2008


The analysis of lung cancer patients (LCP) survival during 5 year period after diagnosis of disease
Source: Eur Respir J 2006; 28: Suppl. 50, 88s
Year: 2006

Asthma control (AC) 1 year after pulmonary rehabilitation (PR)
Source: Annual Congress 2011 - Challenges in rehabilitation: some old dilemmas revisited with some solutions?
Year: 2011


Treatment outcomes of tuberculosis patients under directly observed therapy (DOT) for three years
Source: Eur Respir J 2004; 24: Suppl. 48, 653s
Year: 2004

Upper age limit for bronchiolitis: 12 months or 6 months?
Source: Eur Respir J 2012; 39: 787-788
Year: 2012


Upper age limit for bronchiolitis: 12 months or 6 months?
Source: Eur Respir J 2012; 39: 788-789
Year: 2012


Inpatient resource utilisation in younger (2-5 yrs) and older (6-14 yrs) asthmatic children in Finland
Source: Eur Respir J 2002; 20: 397-402
Year: 2002



Dose selection and pharmacokinetics of montelukast (sprinkles) in >=6 month to <2 year old asthmatic patients
Source: Eur Respir J 2002; 20: Suppl. 38, 525s
Year: 2002